Lilly is committed to patient safety and our goal is to ensure the benefits and risks of a medication are continuously monitored and well-understood by regulators, healthcare providers and patients.
Lilly maintains a pharmacovigilance system, collecting data throughout the lifecycle of each product. This system is designed to continually maintain and evaluate the product's benefit/risk profile. When important safety issues arise, Lilly communicates them to doctors, patients and regulatory agencies.
REPORT AN ADVERSE EVENT
We take patient safety very seriously - click here to report an adverse event